Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020658

President and CEO sold 5,380 shares at an average $0.38 ($2,044)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-11 Sale : show line 1 in the form 10b5-1 −2,731 $0.37 $1,010 712,692 D
2023-07-12 Sale : show line 2 in the form 10b5-1 −2,649 $0.39 $1,033 710,043 D
Open-market sales · 5,380 sh · avg $0.38 · $2,044
Loading xslF345X04/form4.xml…